Illumina Acquires BlueBee to Accelerate Processing, Analysis and Sharing of Next Generation Sequencing Data at Scale
Foundation Medicine Acquires Lexent Bio, Inc., to Accelerate Liquid Biopsy Research and Development, and Advance Cancer Care
JP Morgan 2019 – Drug pricing, drug development, immunotherapy, cancer moonshot, cell/gene-therapy, …
The Biologists and Clinicians Still Require Hand-Holding When it Comes to Sequence Data Analysis and Interpretation
Just Released – Our New NGS Process Report! Market Trends, Unmet Needs and Challenges, and Ecosystem Analysis